One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Epigenetics Market

エピジェネティクス市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2022年


[ 英語タイトル ] Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022


Product Code : MNMHC00108896
Survey : MarketsandMarkets
Publish On : August, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The Global Epigenetics Market Is Projected to Register a CAGR of 13.5% During the Forecast Period (2017–2022).”
The global epigenetics market is projected to reach USD 1,605.7 million by 2022 from USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing sequencing costs and time, increasing research activities, favorable funding scenario for epigenetics research, rising prevalence of cancer are the key factors driving market growth during the forecast period. On the other hand, the high cost of instruments is expected to restrain the growth of this market to a certain extent.
“Oncology Segment Dominated the Global Epigenetics Market, by Application, in 2016”
On the basis of application, the epigenetics market is segmented into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications (includes neurology, gynecology, and infectious diseases). In 2016, the oncology segment accounted for the major share of the global epigenetics market. The large share of this segment is attributed to the rising prevalence of cancer and the increasing number of research-related activities.
“Pharmaceutical and Biotechnology Companies to Register the Highest Growth Rate During the Forecast Period”
On the basis of end users, the epigenetics market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment is expected to register the highest CAGR during the forecast period, owing to increasing research in the areas of genomics with a strong focus on personalized medicine.
“APAC to Witness the Highest Growth Rate During the Forecast Period”
The global epigenetics market is broadly segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. North America accounted for the largest share of the global epigenetics market in 2016, while Asia Pacific is projected to register the highest growth rate during the forecast period. Factors such as increasing R&D spending, favorable government initiatives, and rising focus of key market players on enhancing their presence in this region are supporting the growth of the epigenetics market in the Asia Pacific.
The breakup of primary participants has been mentioned below:
• By Company Type – Tier 1: 35%, Tier 2–40% and Tier 3–25%
• By Designation – C Level: 33%, Director Level: 41%, Others: 26%
• By Region – North America: 35%, Europe: 30%, Asia Pacific: 21%, and RoW: 14%
The prominent players in the epigenetics market include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).
Research Coverage:
The report aims at estimating the market size and future growth potential of the epigenetics market for different segments such as product, application, technology, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.
The report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the epigenetics market
 Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the epigenetics market
 Market Development: Comprehensive information about lucrative emerging markets, by product, application, technology, end user, and region
 Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the epigenetics market
 Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the epigenetics market

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 21
2.1.2.1 Key Data from Primary Sources 22
2.1.2.2 Key Industry Insights 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 MARKET SHARE ESTIMATION 27
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 EPIGENETICS MARKET: OVERVIEW 32
4.2 EPIGENETICS MARKET: DEVELOPED VS DEVELOPING COUNTRIES 32
4.3 GEOGRAPHIC SNAPSHOT: EPIGENETICS MARKET (2016) 33
4.4 GEOGRAPHIC MIX: EPIGENETICS MARKET 34
4.5 APAC: EPIGENETICS MARKET, BY TECHNOLOGY 34
4.6 EPIGENETICS KITS MARKET SIZE, BY TYPE (2017 VS. 2022) 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 KEY MARKET DYNAMICS 36
5.2.1 MARKET DRIVERS 37
5.2.1.1 Declining sequencing costs and time 37
5.2.1.2 Increasing research activities and availability of government funding 38
5.2.1.3 Rising cancer prevalence 38
5.2.2 MARKET RESTRAINTS 39
5.2.2.1 High cost of instruments 39
5.2.3 MARKET OPPORTUNITIES 39
5.2.3.1 High growth potential in emerging markets 39
5.2.3.2 Growing applications of epigenetics in personalized medicine and targeted therapy 40
5.2.3.3 Use of epigenetics in non-oncology applications 40
5.2.4 MARKET CHALLENGES 41
5.2.4.1 Dearth of trained professionals 41
5.2.4.2 Concerns regarding the quality of antibodies 41
6 EPIGENETICS MARKET, BY PRODUCT 42
6.1 INTRODUCTION 43
6.2 KITS 44
6.2.1 CHIP-SEQ KITS 45
6.2.2 BISULFITE CONVERSION KITS 46
6.2.3 WHOLE-GENOME AMPLIFICATION KITS 47
6.2.4 5-HMC AND 5-MC ANALYSIS KITS 48
6.2.5 RNA SEQUENCING KITS 49
6.2.6 OTHER EPIGENETICS KITS 50
6.3 REAGENTS 51
6.3.1 ANTIBODIES 53
6.3.2 MAGNETIC BEADS 54
6.3.3 HISTONES 55
6.3.4 BUFFERS 56
6.3.5 PRIMERS 57
6.3.6 OTHER EPIGENETICS REAGENTS 58
6.4 ENZYMES 59
6.4.1 DNA-MODIFYING ENZYMES 60
6.4.2 PROTEIN-MODIFYING ENZYMES 61
6.4.3 RNA-MODIFYING ENZYMES 62
6.5 INSTRUMENTS AND CONSUMABLES 63
6.5.1 NEXT-GENERATION SEQUENCERS 65
6.5.2 QPCR INSTRUMENTS 66
6.5.3 MASS SPECTROMETERS 67
6.5.4 SONICATORS 68
6.5.5 OTHER INSTRUMENTS AND CONSUMABLES 69
6.6 BIOINFORMATICS TOOLS 70
7 EPIGENETICS MARKET, BY APPLICATION 71
7.1 INTRODUCTION 72
7.2 ONCOLOGY 73
7.3 METABOLIC DISEASES 75
7.4 DEVELOPMENTAL BIOLOGY 77
7.5 IMMUNOLOGY 78
7.6 CARDIOVASCULAR DISEASES 79
7.7 OTHER APPLICATIONS 80
8 EPIGENETICS MARKET, BY TECHNOLOGY 81
8.1 INTRODUCTION 82
8.2 DNA METHYLATION 83
8.3 HISTONE MODIFICATION 84
8.4 OTHER TECHNOLOGIES 85
9 EPIGENETICS MARKET, BY END USER 86
9.1 INTRODUCTION 87
9.2 ACADEMIC AND RESEARCH INSTITUTES 88
9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 89
9.4 CONTRACT RESEARCH ORGANIZATIONS 90
10 EPIGENETICS MARKET, BY REGION 91
10.1 INTRODUCTION 92
10.2 NORTH AMERICA 94
10.2.1 US 98
10.2.2 CANADA 102
10.3 EUROPE 106
10.3.1 GERMANY 109
10.3.2 UK 113
10.3.3 FRANCE 116
10.3.4 ITALY 120
10.3.5 SPAIN 123
10.3.6 REST OF EUROPE 127
10.4 ASIA PACIFIC 131
10.4.1 JAPAN 135
10.4.2 CHINA 139
10.4.3 INDIA 142
10.4.4 REST OF ASIA PACIFIC 146
10.5 LATIN AMERICA 150
10.6 MIDDLE EAST AND AFRICA 153
11 COMPETITIVE LANDSCAPE 158
11.1 INTRODUCTION 158
11.2 MARKET SHARE ANALYSIS (2016) 158
11.3 COMPETITIVE SITUATIONS & TRENDS 159
11.3.1 PRODUCT LAUNCHES & ENHANCEMENT 160
11.3.2 ACQUISITIONS 160
11.3.3 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 161
11.3.4 EXPANSIONS 161
11.3.5 OTHER DEVELOPMENTS 162
12 COMPANY PROFILES 163
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 ILLUMINA 163
12.2 THERMO FISHER SCIENTIFIC 167
12.3 MERCK MILLIPORE 173
12.4 ABCAM 178
12.5 ACTIVE MOTIF 184
12.6 BIO-RAD 188
12.7 NEW ENGLAND BIOLABS 191
12.8 AGILENT 195
12.9 QIAGEN 200
12.10 ZYMO RESEARCH 204
12.11 PERKINELMER 208
12.12 DIAGENODE 212
*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 216
13.1 DISCUSSION GUIDE 216
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 222
13.4 AVAILABLE CUSTOMIZATIONS 224
13.5 RELATED REPORTS 224
13.6 AUTHOR DETAILS 225

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+